Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor

Affiliations

• ¹ Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center, Phoenix, AZ.
• ² Multiple Myeloma Program, Dana-Farber Cancer Institute, Boston, MA.
• ³ Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. Electronic address: Faimanb@ccf.org.
• ⁴ Winship Cancer Institute, Emory University, Atlanta, GA.
• ⁵ Medical Director for the University of Alabama Blood and Marrow Transplantation Program, University of Alabama at Birmingham, Birmingham, AL.
• ⁶ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
• ⁷ Division Chief, Multiple Myeloma, Hackensack Meridian Health, Hackensack, NJ.
• ⁸ Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, NY.